584 related articles for article (PubMed ID: 31030476)
21. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
[TBL] [Abstract][Full Text] [Related]
22. Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.
Manganaro L; Saldari M; Pozza C; Vinci V; Gianfrilli D; Greco E; Franco G; Sergi ME; Scialpi M; Catalano C; Isidori AM
Eur Radiol; 2018 Feb; 28(2):554-564. PubMed ID: 28856410
[TBL] [Abstract][Full Text] [Related]
23. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
[TBL] [Abstract][Full Text] [Related]
24. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
[TBL] [Abstract][Full Text] [Related]
25. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
[TBL] [Abstract][Full Text] [Related]
26. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
[TBL] [Abstract][Full Text] [Related]
28. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
29. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
Lang N; Yuan H; Yu HJ; Su MY
Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of Benign From Malignant Sinonasal Masses Using Diffusion Weighted Imaging and Dynamic Contrast Enhanced Magnetic Resonance Imaging.
Daga R; Kumar J; Pradhan G; Meher R; Malhotra V; Khurana N
Am J Rhinol Allergy; 2022 Mar; 36(2):207-215. PubMed ID: 34486401
[TBL] [Abstract][Full Text] [Related]
33. Prospective evaluation of 3T MRI findings for primary adnexal lesions and comparison with the final histological diagnosis.
Zhang H; Zhang GF; He ZY; Li ZY; Zhang GX
Arch Gynecol Obstet; 2014 Feb; 289(2):357-64. PubMed ID: 23934242
[TBL] [Abstract][Full Text] [Related]
34. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
[TBL] [Abstract][Full Text] [Related]
35. Improved performance in differentiating benign from malignant sinonasal tumors using diffusion-weighted combined with dynamic contrast-enhanced magnetic resonance imaging.
Wang XY; Yan F; Hao H; Wu JX; Chen QH; Xian JF
Chin Med J (Engl); 2015 Mar; 128(5):586-92. PubMed ID: 25698188
[TBL] [Abstract][Full Text] [Related]
36. Quantitative multiparametric MRI of ovarian cancer.
Carter JS; Koopmeiners JS; Kuehn-Hajder JE; Metzger GJ; Lakkadi N; Downs LS; Bolan PJ
J Magn Reson Imaging; 2013 Dec; 38(6):1501-9. PubMed ID: 23559453
[TBL] [Abstract][Full Text] [Related]
37. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
Wang YZ; Xian JF; Wang XY; Guo J; Song LY
Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
[No Abstract] [Full Text] [Related]
38. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors.
Li HM; Qiang JW; Ma FH; Zhao SH
J Ovarian Res; 2017 Jan; 10(1):4. PubMed ID: 28088245
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
Oh E; Yoon YC; Kim JH; Kim K
Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI.
Mori N; Tsuchiya K; Sheth D; Mugikura S; Takase K; Katscher U; Abe H
Eur Radiol; 2019 Apr; 29(4):1778-1786. PubMed ID: 30255252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]